1AD 4.00% 2.4¢ adalta limited

That's in animals in 2022. We've seen pretty good...

  1. 1,459 Posts.
    lightbulb Created with Sketch. 492
    That's in animals in 2022. We've seen pretty good pre-clinical data already, but it's results in IPF patients that we won't see til the middle of FY24 now.

    It's that part of the phase I that I had really been looking forward to, now it's canceled.
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.